4,4'-(9H-Fluorene-9,9-diyl)bis(2-methylphenol), 95.0%, 25g

Benzyl Acrylate (stabilized with MEHQ)>97.0%(GC)25g

Methyl 7-methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylate, 95.0%, 5g

9H-Imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylic acid, 11,12,13,13a-tetrahydro-7-methoxy-9-oxo-, ethyl ester, (13aS)-, 98%, 25mg

4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine, 95.0%, 1g

2-(3-Fluorophenyl)-2-oxoacetaldehyde, 97%, 10g

(S)-2-((tert-Butoxycarbonyl)amino)-3-(quinolin-2-yl)propanoic acid, 95.0%, 100mg

4-Ethoxy-2,3-difluoro-4'-(trans-4-propylcyclohexyl)-1,1'-biphenyl, 95.0%, 1g

3-{[(3-chlorophenyl)sulfonyl]amino}propanoic acid, 95.0%, 1g

5-(Benzyloxy)-2,4-dichloropyrimidine, 95.0%, 5g

2-AMINO-4-BROMO-6-FLUOROBENZALDEHYDE, 95.0%, 250mg

6-BROMO-2-(METHYLTHIO)-QUINAZOLINE, 95.0%, 250mg

Fmoc-N-methyl-3-(2-naphthyl)-L-alanine, 98%, 1g